Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Saab Signs Contract for Training Systems to the Finnish Army

Saab has signed a contract with the Finnish Defence Forces Logistics Command Headquarters (FDFLCHQ) for deliveries of training systems to the Finnish Army. The order value amounts to approximately SEK 47 million and deliveries will start in 2018.Saab provides the Finnish Army with expert training support for KASI, its mobile Combat Training Centre (CTC). Saab sets up, supports and moves the mobile combat training centre to different training sites. This provides soldiers and officers of the Finnish Defence Forces with resources for tactical training at all levels. Included in the contract

Correction to Atria Plc's company announcement April 26, 2018 decisions of the Annual General Meeting

Atria Plc   Company Announcement, 27 April 2018 at 10.00 am Correction to Atria Plc's company announcement April 26, 2018 decisions of the Annual General Meeting The Finnish and English releases lacked an appendix describing the Articles of Association as amended and approved at the Annual General Meeting of 26 April 2018. The whole release together with the appendix: Decisions of Atria Plc's Annual General MeetingAtria Plc's Annual General Meeting was held today in Helsinki at the Finlandia Hall. The General Meeting adopted the financial statements and the consolidated

EQT Infrastructure to sell IslaLink to Fiera Infrastructure

· EQT Infrastructure to sell IslaLink, the Spanish independent and neutral fiber infrastructure provider, to Fiera Infrastructure · IslaLink provides indispensable telecom infrastructure in and around the Balearic Islands, operating the only route-redundant fiber infrastructure connecting Mallorca and Ibiza with the Spanish mainland · IslaLink also owns and operates terrestrial fiber ring in Mallorca providing local operators with neutral and independent fiber infrastructure services · During EQT Infrastructure’s ownership, IslaLink has been transformed to a focused and

Asarina Pharma: First patients begin Phase IIB trials of world’s first-ever therapy developed specifically to treat PMDD

Stockholm – April 24, 2018. The first patients arrived in clinics in Krakow, Poland and Berlin, Germany to take part in Phase IIB trials of the world’s first treatment for PMDD. CEO Peter Nordkild: “This is a milestone moment. Already having patients in the clinic, only ten days after the study opened, underlines the powerful need for a treatment that will alleviate the misery of the severest form of PMS.”The phase IIB study is recruiting 225-250 patients from Sweden, UK, Germany and Poland, to trial Sepranolone in PMDD. It’s an endogenous compound, naturally occurring in the brain, which

Presentation of Probi’s Q1 report 2018

Probi’s report for the first quarter 2018 will be published on Wednesday, 2 May at 8.00 a.m. CET In conjunction with this, analysts, investors and media are invited to an audiocast telephone conference on the same day at 10.00 a.m., where CFO Jörn Andreas will present and comment on the report. The presentation and presentation material can be obtained via www.probi.com  orhttps://tv.streamfabriken.com/probi-q1-2018 The presentation can also be followed via a telephone conference on the following telephone number:Sweden: +46 8 50 55 64 53UK: +44 20 30 08 98

Successful Workday Integration for Finnair

Zalaris and Finnair have a history of co-operation spanning over several years. Previously, Zalaris as the payroll provider was also in charge of employee data management in the Zalaris SAP environment, but along with the Finnair HR system renewal, Finnair took over the employee master data ownership. ”Previously updating employee master data was only done from the payroll management point of view. It was seen to be enough to have the necessary information in store to handle the payment of salaries. However, employee master data has a much larger significance to us than just payroll

HiQ acquires and grows in Linköping

HiQ acquires Indentive’s consulting business and enters a development partnership. As part of the acquisition, HiQ takes over around 20 employees from Indentive.“This acquisition is an excellent expansion of our current business in the region and enhances our team offering so we can meet our customers’ needs even more efficiently,” says Lars Stugemo, CEO and President of HiQ.“We are now entering the next phase, from technology and development to commercialisation, and are concentrating on establishing a market position and customer base for our products Connective, Eagle and Vodvision.

Invitation to the presentation of Catena Media´s interim report January – March 2018

Catena Media´s interim report for January – March 2018 will be published Friday May 4 at 08.30 CET. A combined telephone conference with the opportunity to ask questions will be held at 09.00 CET on the same day, with acting CEO Henrik Persson Ekdahl and CFO Pia-Lena Olofsson presenting the report. The former CFO, Clas Wenthzel, will also be available for questions. The presentation will also be simultaneously webcasted here . The presentation will be held at Helio T-House. Engelbrektsgatan 1, in Stockholm. Breakfast will be served from 08.

Thailand’s largest telecom company AIS signs agreement for Cxense DMP

Oslo, Norway – 27 April 2018 – Cxense ASA (OSE: CXENSE) today announced that AIS, the largest telecom company in Thailand, has signed an agreement with Cxense for the use of its Data Management Platform (DMP).AIS, or Advanced Info Service Plc, is Thailand's leading telecom company with more than 40 million mobile subscribers, a significant broadband operation based on fibre optic lines and an expanding digital services division. The company is listed on the Stock Exchange of Thailand and the main shareholder Intouch plc, is controlled by Temasek Holdings, an investment company owned by

Interim Report January – March 2018

Increased market presence results in greater interest for ChromoGenics’ dynamic glassesQ1 2018 · Net sales for the period amounted to SEK 1.9 (1.0) million. · Earnings for the period amounted to SEK -21.3 (-13.3) million, which corresponds to earnings per share of SEK -0.64 (-1.21). During the quarter, a provision was made for SEK 3.2 million related to the change in CEO. · Cash and cash equivalents as at March 31 amounted to SEK 48.3 million. · ChromoGenics invoiced final deliveries of dynamic glass to Atrium Ljungberg’s project Gränbystaden in Uppsala. · ChromoGenics

Moberg Pharma completes divestment of Balmex® for $4.25 million

STOCKHOLM, April 27th 2018, Moberg Pharma AB (OMX: MOB) has completed the divestment of the Balmex® brand to Randob Labs for a total consideration of $4.25 million plus the inventory value. The divestment results in a capital gain of circa $0.5 million.The brand Balmex®, with a number of products for treating and preventing diaper rash, was acquired from Chattem Inc. in April, 2015. The role of Balmex® in the product portfolio has reduced after the 2016 acquisitions. Divesting the brand, enables Moberg Pharma to focus resources on its larger and more profitable brands. The brand generated

Invitation to NetEnt’s Capital Markets Day on May 22

NetEnt invites analysts, investors and media to its capital markets day on May 22, 2018, at Convendum on Vasagatan 16 in Stockholm, Sweden. The event will start at 9:00 a.m. and end approximately at 14:30 p.m. CET.The first part of the day will include presentations by acting CEO Therese Hillman and Chief Product Officer Henrik Fagerlund, among others. The presentations will be focused on NetEnt’s overall strategy, products, markets and growth opportunities. The presentations will be held in English. After lunch, participants will also be given the opportunity to try out NetEnt´s

Preferential rights issue in NeuroVive oversubscribed

THIS DOCUMENT IS NOT TO BE DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE US, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEELAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR IN ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE SUBJECT TO LEGAL RESTRICTIONS.  Lund, April 27, 2018 - NeuroVive Pharmaceutical AB (publ) ("NeuroVive" or the "Company") (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced the outcome of the preferential rights issue of units consisting of shares and warrants, approved at the Extraordinary General Meeting on March 22, 2018 ("Rights Issue")

Stora Enso Interim Report January–March 2018

Accelerated profitable growth continues; promising start of the yearSTORA ENSO OYJ, Helsinki, FinlandINTERIM REPORT 27 April 2018 at 9.30 EESTQ1/2018 (year-on-year) · Sales increased by 3.3% to EUR 2 579 (2 497) million, primarily due to favourable prices and the ramp-up of strategic investments. · Operational EBIT increased 72% to EUR 369 (215) million as announced on 13 April, mainly due to favourable prices and mix optimisation combined with continued successful ramp-ups of the strategic investments. · The operational EBIT margin was 14.3% (8.6%), the highest for any

YIT and the City of Helsinki are planning a city block in Kruunuvuorenranta

YIT CORPORATION Press release, April 27, 2018, 09:30 a.m.YIT and the City of Helsinki are planning a city block in Kruunuvuorenranta The City of Helsinki has begun negotiations on the construction of a block in Kruunuvuorenranta with YIT Construction Ltd. YIT was selected as the negotiating partner in a competition organised by the city last autumn. The city was looking for a suitable concept and a contractor, and YIT and its consortium* presented the best preliminary plan. The city and YIT are collaborating on the development a project plan that will serve as the basis of a local

INTERIM REPORT 1 JANUARY – 31 MARCH 2018

First quarter 2018, compared to 2017, Group » Group net sales increased by 135% to SEK 1.1m (0.5) » Gross order intake amounted to SEK 0.9m (0.7) an increase of 10.1% » Order backlog amounted to SEK 0.5m (0.5) » 34% growth in orders for Episealer® knee implants during the quarter with 39 (29) approved orders » Loss before tax amounted to SEK –13.3m (–19.0) » Earnings per share (weighted average) amounted to SEK –0.44 (–0.94) Significant events during the first quarter » Episurf Medical continued regulatory preparations and industrial partnership discussions in the US

Resolutions at the Annual General Meeting in Biotage AB on April 26, 2018

At the Annual General Meeting held in Biotage AB (Reg. No. 556539-3138) on April 26, 2018, the following resolutions were passed, among others. Appropriation of the company’s resultThe General Meeting resolved a dividend of SEK 1.40 per share, which in aggregate is a dividend in the amount of no higher than SEK 90,600,226 and to carry forward SEK 380,532,356. Record date for dividend was resolved to be Monday 30 April 2018. Discharge, Board of Directors. Auditors etc.The General Meeting resolved to grant discharge to the Board of Directors and the Chief Executive Officer.

MEDIVIR AB – INTERIM REPORT JANUARY – MARCH 2018

Successful financing enables project portfolio advancementSignificant events during the quarter · The holders of series A shares have notified the Company that they will convert all their series A shares to series B shares. · Successful completion of pre-clinical safety studies with MIV-818, enabling start of phase I clinical studies in 2018. · Preclinical data on MIV-818 were presented at the 2018 HCC Summit organized by the European Association for the Study of the Liver. The data demonstrating targeting of the active metabolite to the liver and identifying potential biomarkers

Stillfront Group AB: Notice of AGM in Stillfront Group AB (publ)

Press ReleaseApril 27, 2018 Notice of annual general meeting in Stillfront Group AB (publ) The shareholders of Stillfront Group AB (publ), reg. no. 556721-3078 ("Company"), are hereby convened to the annual general meeting on Wednesday 30 May 2018 at 11.00 am. The general meeting will be held at the offices of the law firm Advokatfirma DLA Piper Sweden KB at Kungsgatan 9 in Stockholm. The right to participate at the general meeting etc.Shareholders who wish to participate at the general meeting shall i) be registered in the share register kept by Euroclear Sweden AB on the

Raisio plc’s interim report January-March 2018 will be published on 4 May 2018

Raisio plcPress release Raisio plc’s interim report January-March 2018 will be published on 4 May 2018 Raisio plc will publish its interim report January-March 2018 on Friday, 4 May 2018 at about 8:30 a.m. Finnish time. We will also publish President and CEO Pekka Kuusniemi’s video where he sums up the first quarter results. The video will be published at www.raisio.com. RAISIO PLC Heidi HirvonenCommunications and IR Managerheidi.hirvonen@raisio.comtel. +358 50 567 3060 Raisio plc Raisio is an international company specialised in healthy, responsibly produced

Stora Enso’s financial reports and AGM in 2019

STORA ENSO OYJ STOCK EXCHANGE RELEASE 27 April 2018 at 9.29 EESTFinancial report dates in 2019Stora Enso Oyj will publish four interim reports in 2019. The publication dates for financial information will be as follows: Friday   1 February 2019 Financial   Statement Release for 2018Thursday   25 April 2019 Interim Report for January–March 2019Friday   19 July 2019 Half-year Report for January–June 2019Tuesday   29 October 2019 Interim Report for January–September 2019 The financial reports are published at approximately 9.30 Finnish time. Stora Enso follows a silent

NextCell enters into Memorandum of Agreement with China General Consulting & Investment Co., Ltd.

NextCell Pharma AB ("NextCell") hereby announces that the company has entered a Memorandum of Agreement with China General Consulting & Investment Co., Ltd. (”CGCI”). The purpose of the agreement is to create a base for future co-operation. The agreement includes that the parties should prioritize working together when it comes to stem cell development and China, but is otherwise without claims or obligations and does not affect NextCell financially.NextCell has developed a patented applied for selection algorithm to ensure the selection and production of potent mesenchymal stem cells in

There are no items matching the current filter
There are no more items matching the current filter
Back to top